PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
28-Jun-2020 Chi-Med Announces US$100 Million Equity Investment by General Atlantic Chi-Med
26-Jun-2020 JANSSEN EXPRESSES DISAPPOINTMENT WITH NICE FINAL APPRAISAL DOCUMENT DENYING MEN WITH AGGRESSIVE, EARLY PROSTATE CANCER ACCESS TO ZYTIGA® (ABIRATERONE ACETATE) Janssen
26-Jun-2020 (Covid-19) Impact Analysis : Dental Handpiece-Contra Angle Market Size, Trends, Analysis, Demand, Outlook and Forecast to 2026 Qurate Business Intelligence
24-Jun-2020 Oculis to Present at the Upcoming Virtual European Biotech Investor Day 2020 Oculis
24-Jun-2020 MSF calls on Gavi to revise its global mechanism and demand pharma sell all COVID-19 vaccines at cost Gavi
24-Jun-2020 Publication of Data from Severe COVID-19 Patients Shows Substantial Benefit to Patients Treated with RedHill’s Opaganib Compared to Matched Case-Control Group RedHill Biopharma
24-Jun-2020 GW Pharmaceuticals announces that EPIDYOLEX® (cannabidiol) has been reclassified by the UK Home Office as a Schedule 5 drug GW Pharmaceuticals plc
24-Jun-2020 Roivant Sciences continues its partnership with BaseLaunch for Phase II Roivant Sciences
24-Jun-2020 Zelluna Immunotherapy announces a collaboration with Lion TCR to develop allogeneic “off-the-shelf” TCR based Natural Killer (TCR-NK) cell therapies for the treatment of virally induced cancers Zelluna Immunotherapy
24-Jun-2020 Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial Evelo Biosciences
24-Jun-2020 2018-19 Figures Show Almac Group’s Turnover Increased by £85M to £634M 7% growth in global workforce to over 5,100 during same period Almac Group
24-Jun-2020 Transgene presents promising new data from its next-generation immunotherapy platforms at AACR 2020 Transgene
24-Jun-2020 PureTech Presents New Data Reinforcing Galectin-9 as a Compelling Therapeutic Target and Biomarker for a Range of Cancers at the American Association for Cancer Research Annual Meeting PureTech Health plc
24-Jun-2020 Jubilant Therapeutics Presents Preclinical Data at the American Association for Cancer Research, Reveals Unique Dual-Action Anti-Cancer Mechanism Underscoring First-in-Class Pipeline Asset in Hematological Tumors Jubilant Therapeutics Inc
24-Jun-2020 Autolus Therapeutics presents new preclinical data during the Virtual 2020 AACR Annual Meeting Autolus Therapeutics
24-Jun-2020 Intranasal immunization with Intravacc’s experimental whooping cough vaccine confers broad protection Intravacc
24-Jun-2020 Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial Evelo Biosciences
23-Jun-2020 UK Public Cite Greater Concern over the Future of the National Health Service (NHS) and the UK Economy than Their Own Health or Online Threats, According to Unisys Security Index™ RealWire
22-Jun-2020 Clinerion’s Patient Network Explorer offers clinical trial performance data for sites in its global site network. Clinerion Ltd.
19-Jun-2020 RedHill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK RedHill Biopharma